United States Primary Hyperoxaluria Drug Market Report & Forecast 2021-2027

United States Primary Hyperoxaluria Drug Market Report & Forecast 2021-2027

Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Primary Hyperoxaluria Drug Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 United States Primary Hyperoxaluria Drug Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year
2 United States Primary Hyperoxaluria Drug Overall Market Size
2.1 United States Primary Hyperoxaluria Drug Market Size: 2021 VS 2027
2.2 United States Primary Hyperoxaluria Drug Revenue, Prospects & Forecasts: 2016-2027
2.3 United States Primary Hyperoxaluria Drug Sales: 2016-2027
3 Company Landscape
3.1 Top Primary Hyperoxaluria Drug Players in United States Market
3.2 Top United States Primary Hyperoxaluria Drug Companies Ranked by Revenue
3.3 United States Primary Hyperoxaluria Drug Revenue by Companies
3.4 United States Primary Hyperoxaluria Drug Sales by Companies
3.5 United States Primary Hyperoxaluria Drug Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Primary Hyperoxaluria Drug Companies in United States Market, by Revenue in 2020
3.7 Manufacturers Primary Hyperoxaluria Drug Product Type
3.8 Tier 1, Tier 2 and Tier 3 Primary Hyperoxaluria Drug Players in United States Market
3.8.1 List of Tier 1 Primary Hyperoxaluria Drug Companies in United States
3.8.2 List of Tier 2 and Tier 3 Primary Hyperoxaluria Drug Companies in United States
4 Sights by Type
4.1 Overview
4.1.1 By Type - United States Primary Hyperoxaluria Drug Market Size Markets, 2021 & 2027
4.1.2 ALLN-230
4.1.3 DCR-PHXC
4.1.4 ALN-GO1
4.1.5 Others
4.2 By Type - United States Primary Hyperoxaluria Drug Revenue & Forecasts
4.2.1 By Type - United States Primary Hyperoxaluria Drug Revenue, 2016-2021
4.2.2 By Type - United States Primary Hyperoxaluria Drug Revenue, 2022-2027
4.2.3 By Type - United States Primary Hyperoxaluria Drug Revenue Market Share, 2016-2027
4.3 By Type - United States Primary Hyperoxaluria Drug Sales & Forecasts
4.3.1 By Type - United States Primary Hyperoxaluria Drug Sales, 2016-2021
4.3.2 By Type - United States Primary Hyperoxaluria Drug Sales, 2022-2027
4.3.3 By Type - United States Primary Hyperoxaluria Drug Sales Market Share, 2016-2027
4.4 By Type - United States Primary Hyperoxaluria Drug Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - United States Primary Hyperoxaluria Drug Market Size, 2021 & 2027
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Others
5.2 By Application - United States Primary Hyperoxaluria Drug Revenue & Forecasts
5.2.1 By Application - United States Primary Hyperoxaluria Drug Revenue, 2016-2021
5.2.2 By Application - United States Primary Hyperoxaluria Drug Revenue, 2022-2027
5.2.3 By Application - United States Primary Hyperoxaluria Drug Revenue Market Share, 2016-2027
5.3 By Application - United States Primary Hyperoxaluria Drug Sales & Forecasts
5.3.1 By Application - United States Primary Hyperoxaluria Drug Sales, 2016-2021
5.3.2 By Application - United States Primary Hyperoxaluria Drug Sales, 2022-2027
5.3.3 By Application - United States Primary Hyperoxaluria Drug Sales Market Share, 2016-2027
5.4 By Application - United States Primary Hyperoxaluria Drug Price (Manufacturers Selling Prices), 2016-2027
6 Manufacturers & Brands Profiles
6.1 Allena Pharmaceuticals Inc
6.1.1 Allena Pharmaceuticals Inc Corporation Information
6.1.2 Allena Pharmaceuticals Inc Overview
6.1.3 Allena Pharmaceuticals Inc Primary Hyperoxaluria Drug Sales and Revenue in United States Market (2016-2021)
6.1.4 Allena Pharmaceuticals Inc Primary Hyperoxaluria Drug Product Description
6.1.5 Allena Pharmaceuticals Inc Recent Developments
6.2 Alnylam Pharmaceuticals Inc
6.2.1 Alnylam Pharmaceuticals Inc Corporation Information
6.2.2 Alnylam Pharmaceuticals Inc Overview
6.2.3 Alnylam Pharmaceuticals Inc Primary Hyperoxaluria Drug Sales and Revenue in United States Market (2016-2021)
6.2.4 Alnylam Pharmaceuticals Inc Primary Hyperoxaluria Drug Product Description
6.2.5 Alnylam Pharmaceuticals Inc Recent Developments
6.3 Dicerna Pharmaceuticals Inc
6.3.1 Dicerna Pharmaceuticals Inc Corporation Information
6.3.2 Dicerna Pharmaceuticals Inc Overview
6.3.3 Dicerna Pharmaceuticals Inc Primary Hyperoxaluria Drug Sales and Revenue in United States Market (2016-2021)
6.3.4 Dicerna Pharmaceuticals Inc Primary Hyperoxaluria Drug Product Description
6.3.5 Dicerna Pharmaceuticals Inc Recent Developments
6.4 Intellia Therapeutics Inc
6.4.1 Intellia Therapeutics Inc Corporation Information
6.4.2 Intellia Therapeutics Inc Overview
6.4.3 Intellia Therapeutics Inc Primary Hyperoxaluria Drug Sales and Revenue in United States Market (2016-2021)
6.4.4 Intellia Therapeutics Inc Primary Hyperoxaluria Drug Product Description
6.4.5 Intellia Therapeutics Inc Recent Developments
6.5 OxThera AB
6.5.1 OxThera AB Corporation Information
6.5.2 OxThera AB Overview
6.5.3 OxThera AB Primary Hyperoxaluria Drug Sales and Revenue in United States Market (2016-2021)
6.5.4 OxThera AB Primary Hyperoxaluria Drug Product Description
6.5.5 OxThera AB Recent Developments
7 United States Primary Hyperoxaluria Drug Production Capacity, Analysis
7.1 United States Primary Hyperoxaluria Drug Production Capacity, 2016-2027
7.2 Primary Hyperoxaluria Drug Production Capacity of Key Manufacturers in United States Market
8 Key Market Trends, Opportunity, Drivers and Restraints
8.1 Market Opportunities & Trends
8.2 Market Drivers
8.3 Market Restraints
9 Primary Hyperoxaluria Drug Supply Chain Analysis
9.1 Primary Hyperoxaluria Drug Industry Value Chain
9.2 Primary Hyperoxaluria Drug Upstream Market
9.3 Primary Hyperoxaluria Drug Downstream and Clients
9.4 Marketing Channels Analysis
9.4.1 Marketing Channels
9.4.2 Primary Hyperoxaluria Drug Distributors and Sales Agents in United States Market
10 Conclusion
11 Appendix
11.1 Note
11.2 Examples of Clients
11.3 Author Details
11.4 Disclaimer
List of Tables
Table 1. Key Players of Primary Hyperoxaluria Drug in United States Market
Table 2. Top Primary Hyperoxaluria Drug Players in United States Market, Ranking by Revenue (2019)
Table 3. United States Primary Hyperoxaluria Drug Revenue by Companies, (US$, Mn), 2016-2021
Table 4. United States Primary Hyperoxaluria Drug Revenue Share by Companies, 2016-2021
Table 5. United States Primary Hyperoxaluria Drug Sales by Companies, (K Pcs), 2016-2021
Table 6. United States Primary Hyperoxaluria Drug Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Primary Hyperoxaluria Drug Price (2016-2021) & (USD/Pcs)
Table 8. Manufacturers Primary Hyperoxaluria Drug Product Type
Table 9. List of Tier 1 Primary Hyperoxaluria Drug Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Tier 2 and Tier 3 Primary Hyperoxaluria Drug Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. Major Manufacturers of ALLN-230
Table 12. Major Manufacturers of DCR-PHXC
Table 13. By Type - United States Primary Hyperoxaluria Drug Revenue, (US$, Mn), 2021 & 2027
Table 14. By Type - United States Primary Hyperoxaluria Drug Revenue (US$, Mn), 2016-2021
Table 15. By Type - United States Primary Hyperoxaluria Drug Revenue (US$, Mn), 2022-2027
Table 16. By Type - United States Primary Hyperoxaluria Drug Sales (K Pcs), 2016-2021
Table 17. By Type - United States Primary Hyperoxaluria Drug Sales (K Pcs), 2022-2027
Table 18. By Application - United States Primary Hyperoxaluria Drug Revenue, (US$, Mn), 2021 VS 2027
Table 19. By Application - United States Primary Hyperoxaluria Drug Revenue (US$, Mn), 2016-2021
Table 20. By Application - United States Primary Hyperoxaluria Drug Revenue (US$, Mn), 2022-2027
Table 21. By Application - United States Primary Hyperoxaluria Drug Sales (K Pcs), 2016-2021
Table 22. By Application - United States Primary Hyperoxaluria Drug Sales (K Pcs), 2022-2027
Table 23. Allena Pharmaceuticals Inc Corporation Information
Table 24. Allena Pharmaceuticals Inc Description and Major Businesses
Table 25. Allena Pharmaceuticals Inc Primary Hyperoxaluria Drug Sales (K Pcs), Revenue (US$, Mn) and Gross Margin (USD/Pcs) (2016-2021)
Table 26. Allena Pharmaceuticals Inc Primary Hyperoxaluria Drug Product
Table 27. Allena Pharmaceuticals Inc Recent Developments
Table 28. Alnylam Pharmaceuticals Inc Corporation Information
Table 29. Alnylam Pharmaceuticals Inc Description and Major Businesses
Table 30. Alnylam Pharmaceuticals Inc Primary Hyperoxaluria Drug Sales (K Pcs), Revenue (US$, Mn) and Gross Margin (USD/Pcs) (2016-2021)
Table 31. Alnylam Pharmaceuticals Inc Primary Hyperoxaluria Drug Product
Table 32. Alnylam Pharmaceuticals Inc Recent Developments
Table 33. Dicerna Pharmaceuticals Inc Corporation Information
Table 34. Dicerna Pharmaceuticals Inc Description and Major Businesses
Table 35. Dicerna Pharmaceuticals Inc Primary Hyperoxaluria Drug Sales (K Pcs), Revenue (US$, Mn) and Gross Margin (USD/Pcs) (2016-2021)
Table 36. Dicerna Pharmaceuticals Inc Primary Hyperoxaluria Drug Product
Table 37. Dicerna Pharmaceuticals Inc Recent Developments
Table 38. Intellia Therapeutics Inc Corporation Information
Table 39. Intellia Therapeutics Inc Description and Major Businesses
Table 40. Intellia Therapeutics Inc Primary Hyperoxaluria Drug Sales (K Pcs), Revenue (US$, Mn) and Gross Margin (USD/Pcs) (2016-2021)
Table 41. Intellia Therapeutics Inc Primary Hyperoxaluria Drug Product
Table 42. Intellia Therapeutics Inc Recent Developments
Table 43. OxThera AB Corporation Information
Table 44. OxThera AB Description and Major Businesses
Table 45. OxThera AB Primary Hyperoxaluria Drug Sales (K Pcs), Revenue (US$, Mn) and Gross Margin (USD/Pcs) (2016-2021)
Table 46. OxThera AB Primary Hyperoxaluria Drug Product
Table 47. OxThera AB Recent Developments
Table 48. Primary Hyperoxaluria Drug Production Capacity (K Pcs) of Key Manufacturers in United States Market, 2019-2021 (K Pcs)
Table 49. United States Primary Hyperoxaluria Drug Capacity Market Share of Key Manufacturers, 2019-2021
Table 50. Primary Hyperoxaluria Drug Market Opportunities & Trends in United States Market
Table 51. Primary Hyperoxaluria Drug Market Drivers in United States Market
Table 52. Primary Hyperoxaluria Drug Market Restraints in United States Market
Table 53. Primary Hyperoxaluria Drug Raw Materials
Table 54. Primary Hyperoxaluria Drug Raw Materials Suppliers in United States Market
Table 55. Typical Primary Hyperoxaluria Drug Downstream
Table 56. Primary Hyperoxaluria Drug Downstream Clients in United States Market
Table 57. Primary Hyperoxaluria Drug Distributors and Sales Agents in United States Market
List of Figures
Figure 1. Primary Hyperoxaluria Drug Product Picture
Figure 2. Primary Hyperoxaluria Drug Segment by Type
Figure 3. Primary Hyperoxaluria Drug Segment by Application
Figure 4. United States Primary Hyperoxaluria Drug Market Overview: 2020
Figure 5. United States Primary Hyperoxaluria Drug Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. United States Primary Hyperoxaluria Drug Revenue, 2016-2027 (US$, Mn)
Figure 7. Primary Hyperoxaluria Drug Sales in United States Market: 2016-2027 (K Pcs)
Figure 8. The Top 3 and 5 Players Market Share by Primary Hyperoxaluria Drug Revenue in 2020
Figure 9. ALLN-230 Product Picture
Figure 10. DCR-PHXC Product Picture
Figure 11. ALN-GO1 Product Picture
Figure 12. Others Product Picture
Figure 13. By Type - United States Primary Hyperoxaluria Drug Sales Market Share, 2016-2027
Figure 14. By Type - United States Primary Hyperoxaluria Drug Revenue Market Share, 2016-2027
Figure 15. By Type - United States Primary Hyperoxaluria Drug Price (USD/Pcs), 2016-2027
Figure 16. Hospital
Figure 17. Clinic
Figure 18. Others
Figure 19. By Application - United States Primary Hyperoxaluria Drug Sales Market Share, 2016-2027
Figure 20. By Application - United States Primary Hyperoxaluria Drug Revenue Market Share, 2016-2027
Figure 21. By Application - United States Primary Hyperoxaluria Drug Price (USD/Pcs), 2016-2027
Figure 22. Allena Pharmaceuticals Inc Primary Hyperoxaluria Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 23. Alnylam Pharmaceuticals Inc Primary Hyperoxaluria Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 24. Dicerna Pharmaceuticals Inc Primary Hyperoxaluria Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 25. Intellia Therapeutics Inc Primary Hyperoxaluria Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 26. OxThera AB Primary Hyperoxaluria Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 27. United States Primary Hyperoxaluria Drug Production Capacity (K Pcs), 2016-2027
Figure 28. Primary Hyperoxaluria Drug Industry Value Chain
Figure 29. Marketing Channels

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs